Events

STAPHYTECT PLUS 의 리콜

L’Agence nationale de sécurité du médicament et des produits de santé (ANSM)에 따르면, 해당 리콜 는 France 에서 OXOID 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 날짜
    2003-09-09
  • 사례 국가
    France
  • 사례 출처
    ANSM
  • 사례 출처 URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-de-3-lots-du-dmdiv-staphytect-plus-de-par-la-societe-oxoid
  • 비고 / 경고
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • 데이터 추가 비고
  • 조치
    The company OXOID withdraws from the market lots 288005 (per.28.02.04); 293832 (per.30.04.04) and 300154 (per.30.06.04) of the in vitro diagnostic medical device called STAPHYTECT PLUS - reference DR0850M, following a stability problem that could lead to false positive results. This device is an on-card latex agglutination test, which makes it possible to differentiate between Staphylococcus aureus possessing the clumping factor, protein A and capsular polysaccharides specific for the metastoresistant strains (MRSA) of other staphylococci which do not possess them.

Device

STAPHYTECT PLUS
  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    in-vitro_medical_device
  • Manufacturer
    OXOID

Manufacturer

OXOID
  • Source
    LAANSM